Richard Ettl interviewed by TechCrunch
SkyCell has successfully closed the recent round of Series C funding with $35M. This enables SkyCell to further improve the experience we offer our clients, further differentiate our hardware and SaaS offerings and to become the distribution solution of choice for cold chain.
We were pleased to see our Series C funding round covered by TechCrunch this week. Our CEO and Co-Founder, Richard Ettl, spoke to reporter Emma Betuel about the particulars of the investors and expanded on issues related to the biopharma industry itself.
From highlighting SkyCell’s annually audited excursion rate of less than 0.1% compared to the industry standard, to discussing macro trends within the industry and the company’s expanding partnerships, Emma and Richard tackled many topics of interest.
Read the full article here.
News & Stories
Up to 50% Fewer Emissions, Zero Compromise: The 1500X Hybrid Container
The pharmaceutical industry's carbon footprint continues to rise year on year, with the supply chain alone accounting for an estimated...
1500X Hybrid Containers: Performance Meets Efficiency
Pharma supply chains are highly complex, often involving hundreds of steps across various transport modes, which can lead to inefficiencies,...
Enhanced Performance and Reliability: The 1500X Hybrid Container
SkyCell’s journey began 12 years ago with a challenge: “Can you build a pharma container that keeps +2°C to +8°C...